Genprex Stock (NASDAQ: GNPX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.000 / 86.980K |
Day Range | - - - |
52 Wk Range | 2.090 - 44.000 |
Market Cap | $4.012M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 3.7% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Genprex (NASDAQ: GNPX) through any online brokerage.
Other companies in Genprex’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX) and NexImmune (NASDAQ:NEXI).
The latest price target for Genprex (NASDAQ: GNPX) was reported by HC Wainwright & Co. on Thursday, April 4, 2024. The analyst firm set a price target for 10.00 expecting GNPX to rise to within 12 months (a possible 376.19% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Genprex (NASDAQ: GNPX) is $2.1 last updated April 23, 2024 at 8:20 AM EDT.
There are no upcoming dividends for Genprex.
Genprex’s Q1 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Genprex.
Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.